Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection RK Sterling, E Lissen, N Clumeck, R Sola, MC Correa, J Montaner, ... Hepatology 43 (6), 1317-1325, 2006 | 4335 | 2006 |
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients FJ Torriani, M Rodriguez-Torres, JK Rockstroh, E Lissen, ... New England Journal of Medicine 351 (5), 438-450, 2004 | 1704 | 2004 |
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society–USA Panel CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, BG Gazzard, ... Jama 283 (3), 381-390, 2000 | 1378 | 2000 |
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel SM Hammer, JJ Eron, P Reiss, RT Schooley, MA Thompson, S Walmsley, ... Jama 300 (5), 555-570, 2008 | 1291 | 2008 |
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America JP Lalezari, K Henry, M O'Hearn, JSG Montaner, PJ Piliero, B Trottier, ... New England Journal of Medicine 348 (22), 2175-2185, 2003 | 1217 | 2003 |
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ... Jama 304 (3), 321-333, 2010 | 1147 | 2010 |
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel SM Hammer, MS Saag, M Schechter, JSG Montaner, RT Schooley, ... Jama 296 (7), 827-843, 2006 | 1129 | 2006 |
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy RS Hogg, KV Heath, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter, ... Jama 279 (6), 450-454, 1998 | 1109 | 1998 |
Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society—USA Panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 277 (24), 1962-1969, 1997 | 1048 | 1997 |
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy RS Hogg, B Yip, KJ Chan, E Wood, KJP Craib, MV O'Shaughnessy, ... Jama 286 (20), 2568-2577, 2001 | 1014 | 2001 |
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial JSG Montaner, P Reiss, D Cooper, S Vella, M Harris, B Conway, ... Jama 279 (12), 930-937, 1998 | 1009 | 1998 |
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel PG Yeni, SM Hammer, CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, ... Jama 288 (2), 222-235, 2002 | 985 | 2002 |
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ... The Lancet 376 (9740), 532-539, 2010 | 957 | 2010 |
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society–USA Panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 280 (1), 78-86, 1998 | 905 | 1998 |
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus Centers for Disease Control and Prevention MMWR 46 (RR‐12), 1-48, 1997 | 832* | 1997 |
Needle exchange is not enough: lessons from the Vancouver injecting drug use study SA Strathdee, DM Patrick, SL Currie, PGA Cornelisse, ML Rekart, ... Aids 11 (8), F59-F65, 1997 | 823 | 1997 |
Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ... Jama 276 (2), 146-154, 1996 | 803 | 1996 |
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel PG Yeni, SM Hammer, MS Hirsch, MS Saag, M Schechter, CCJ Carpenter, ... Jama 292 (2), 251-265, 2004 | 739 | 2004 |
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients HCF Côté, ZL Brumme, KJP Craib, CS Alexander, B Wynhoven, L Ting, ... New England Journal of Medicine 346 (11), 811-820, 2002 | 735 | 2002 |
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada W Zhang, N O’Brien, JI Forrest, KA Salters, TL Patterson, JSG Montaner, ... PloS one 7 (7), e40793, 2012 | 726 | 2012 |